An observational, retrospective, comprehensive pharmacovigilance analysis of hydroxychloroquine-associated cardiovascular adverse events in patients with and without COVID-19

BACKGROUND: Coronavirus disease 2019 (COVID-19) is a global pandemic. Hydroxychloroquine (HCQ)-associated cardiovascular adverse events (CVAEs) have been increasingly reported. AIM: This study aimed to present an observational, retrospective, and comprehensive pharmacovigilance analysis of CVAE asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Min, Wu, Bin, Li, Yuwen, Wu, Fengbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297057/
https://www.ncbi.nlm.nih.gov/pubmed/35857159
http://dx.doi.org/10.1007/s11096-022-01457-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297057/
https://www.ncbi.nlm.nih.gov/pubmed/35857159
http://dx.doi.org/10.1007/s11096-022-01457-w

Ejemplares similares